Email Us: info@lupinepublishers.com
Call Us: +1 (914) 407-6109
57 West 57th Street, 3rd floor, New York - NY 10019, USA
Lupine Publishers Group
Lupine Publishers
ISSN: 2641-1687
Research Article(ISSN: 2641-1687) 
Clinical Features, Treatment, and Outcome of Tumor Lysis Syndrome in Germ Cell Tumors
Volume 1 - Issue 4Bryan Leung1, Jeffrey Wang2, Jill Cassaday3 and Jue Wang3*
-
Author Information
Open or Close
Jue Wang, MD, FACP, Professor of Medicine, Director of Genitourinary Oncology Section, University of Arizona Cancer Center at Dignity Health St. Joseph’s, Phoenix, AZ 85004
Received: December 20, 2018; Published: January 04, 2019
DOI: 10.32474/JUNS.2019.01.000116
Full Text
PDFAbstract
Background: Tumor lysis syndrome (TLS) is an oncologic emergency that can occur spontaneously or triggered by cancer treatment. This life-threatening condition is most commonly seen in hematologic cancers but is sometimes described in solid tumors such as germ cell tumors (GCTs). The objective of this study is to investigate the clinical characteristics and outcomes of TLS in GCTs.
Methods: Retrospective review and pooled analysis.
Result: Seventeen cases of TLS related to GCTs were identified. These included nonseminomatous GCT (7), seminoma (5), choriocarcinoma (2), ovarian (2), and intracranial germinoma (1). Nine cases (53%) of TLS were treatment-related and eight cases (47%) occurred spontaneously. The median age of patients was 34 years (range: 13-58), excluding one newborn baby. The median time from treatment to TLS was 2.1 days. Seven patients (41%) had liver metastases, but all patients had bulky disease. All of the patients received supportive measures; 4 (24%) patients received rasburicase and 11 patients (64%) underwent hemodialysis. The mortality rate was 44.4% among the nine cases of treatment-related TLS. The mortality rate was 37.5% in the eight patients with spontaneous TLS (STLS).
Conclusion: TLS can occur in GCTs that have a high tumor burden. Almost 50% of TLS in GCTs happened spontaneously. Considering the life-threatening nature of TLS in GCTs, health professionals should be alert and monitor for TLS in order to prevent or treat this potentially fatal complication.
Keywords: Tumor lysis syndrome (TLS); Oncologic emergency; Germ cell tumors (GCTs); Clinical features, Treatment, and Outcome; Mortality
Abstract| Introduction| Material and Methods| Results| Discussion| Conclusion| Declaration| References|
-
Mark E Smith
Bio chemistry
University of Texas Medical Branch, USA -
Lawrence A Presley
Department of Criminal Justice
Liberty University, USA -
Thomas W Miller
Department of Psychiatry
University of Kentucky, USA -
Gjumrakch Aliev
Department of Medicine
Gally International Biomedical Research & Consulting LLC, USA -
Christopher Bryant
Department of Urbanisation and Agricultural
Montreal university, USA -
Robert William Frare
Oral & Maxillofacial Pathology
New York University, USA -
Rudolph Modesto Navari
Gastroenterology and Hepatology
University of Alabama, UK -
Andrew Hague
Department of Medicine
Universities of Bradford, UK -
George Gregory Buttigieg
Maltese College of Obstetrics and Gynaecology, Europe -
Chen-Hsiung Yeh
Oncology
Circulogene Theranostics, England -
.png)
Emilio Bucio-Carrillo
Radiation Chemistry
National University of Mexico, USA -
.jpg)
Casey J Grenier
Analytical Chemistry
Wentworth Institute of Technology, USA -
Hany Atalah
Minimally Invasive Surgery
Mercer University school of Medicine, USA -
Abu-Hussein Muhamad
Pediatric Dentistry
University of Athens , Greece
